Our articles

March 23, 2022

What’s new for the pharmaceutical industry in the 2021 ABPI Code update?

The Code of Practice for the Pharmaceutical Industry (the code) is published by the Association of the British Pharmaceutical Industry (ABPI) - find out what's new

Read now

January 20, 2022

The Oxford AstraZeneca vaccine and the missed opportunity for professional science communicators

Brain power, collaboration, and sheer hard work underpinned the development of the Oxford/AstraZeneca vaccine, so how have science communicators missed an opportunity to spread the word here?

Read now

December 16, 2020

When every word counts

How you communicate matters. Whether patients are vulnerable in the context of a clinical trial or because of their illness, it's is important to be aware of these factors when strategising a patient communication plan.

Read now

November 25, 2020

One year at Enzyme Communications

Enzyme's company process revolves around four Ps (Position, Promise, Proof and Patient). After year one of working with us, Lois sums up her experience with her own four Ps

Read now

August 10, 2020

Fair and diverse participation in clinical trials: is that even achievable?

Studies show that clinical trials conducted in the United States tend to involve primarily middle and upper-class, younger, white male participants. Ideally of course, a clinical trial’s population would consist of a variety of different sexes, race and ethnicities.

Read now

May 14, 2020

Are you using digital marketing to locate your clinical trial participants?

Figures from 2014 showed that up to 89% of pharmaceutical companies were failing to notice the potential of non-traditional methods of recruitment.[2] While this is no doubt changing, many companies have plenty of room to improve.

Read now

February 26, 2019

How to use social media in healthcare product launches

As everyone is well aware, social media can be a useful tool for business to access target audiences. The same is true in the healthcare environment, where pharmaceutical companies want to reach healthcare professionals to communicate the value proposition of the treatments they produce and market. 

Read now

January 31, 2019

Strategic and tactical innovation in healthcare communications under the GDPR

The General Data Protection Regulation (GDPR) has had many companies focused on data storage, processing and compliance over the last 12-24 months - and rightly so.  As of last week, we have seen that the GDPR has teeth and that regulators intend to enforce the rules.

Read now

January 15, 2019

What does ‘no-deal’ mean for the supply of medicines?

Following today's defeat of the Prime Minister's Brexit deal, many thousands of people up and down the UK will be extremely worried. Not because of the economic or political implications, but because their wellbeing and potentially even their life is dependent on a consistent supply of medicine.

Read now

January 7, 2019

New year, new approach?

Talking about science and selling scientific products and services to varied audiences is often not so different from traditional marketing.

Read now

January 4, 2019

What is science communication?

That’s a great question, and as science communication specialists, it’s a question that we ask ourselves a lot. To answer that question let’s begin with a boat full of sailors in 1747.

Read now

Give us a call

+44 (0) 20 8058 8389

Drop us an email

hello@enzymecomms.com

Visit us

Cargoworks
1-2 Hatfields
London
SE1 9PG

Get in touch